Reduction of TRAIL-induced Mcl-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death.
暂无分享,去创建一个
K. Flaherty | W. El-Deiry | D. Dicker | Wenge Wang | P. Chiao | Zhaoyu Jin | Charles D Smith | J. Ling | J. Plastaras | Seok-Hyun Kim | Yingqiu Liu | M. Ricci | K. Ogi | Yingqiu Y Liu | Yingqiu Y. Liu | Yingqiu Y. Liu
[1] D. Green,et al. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. , 2006, Molecular cell.
[2] J. Clohessy,et al. Mcl-1 Interacts with Truncated Bid and Inhibits Its Induction of Cytochrome c Release and Its Role in Receptor-mediated Apoptosis* , 2006, Journal of Biological Chemistry.
[3] P. Dent,et al. Apoptosis Induced by the Kinase Inhibitor BAY 43-9006 in Human Leukemia Cells Involves Down-regulation of Mcl-1 through Inhibition of Translation* , 2005, Journal of Biological Chemistry.
[4] G. Gores,et al. The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006 , 2005, Oncogene.
[5] Jennifer B. Old,et al. Nfkb1 is dispensable for Myc-induced lymphomagenesis , 2005, Oncogene.
[6] M. Hahne,et al. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Rheumatoid Arthritis Synovial Fibroblast Proliferation through Mitogen-activated Protein Kinases and Phosphatidylinositol 3-Kinase/Akt* , 2005, Journal of Biological Chemistry.
[7] P. Fisher,et al. Positive and negative regulation of EAAT2 by NF‐κB: a role for N‐myc in TNFα‐controlled repression , 2005 .
[8] W. El-Deiry,et al. Overview of cell death signaling pathways , 2005, Cancer biology & therapy.
[9] M. Merville,et al. Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation , 2005 .
[10] W. El-Deiry,et al. Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity , 2004, Molecular and Cellular Biology.
[11] D. Auclair,et al. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis , 2004, Cancer Research.
[12] M. Herlyn,et al. Death Induction by Recombinant Native TRAIL and Its Prevention by a Caspase 9 Inhibitor in Primary Human Esophageal Epithelial Cells* , 2004, Journal of Biological Chemistry.
[13] A. Ashkenazi,et al. Targeting death receptors in cancer with Apo2L/TRAIL. , 2004, Current opinion in pharmacology.
[14] A. Godzik,et al. The Domains of Apoptosis: A Genomics Perspective , 2004, Science's STKE.
[15] Seamus J. Martin,et al. Smac/Diablo Antagonizes Ubiquitin Ligase Activity of Inhibitor of Apoptosis Proteins* , 2004, Journal of Biological Chemistry.
[16] P. Insel,et al. Cyclic AMP Promotes cAMP-responsive Element-binding Protein-dependent Induction of Cellular Inhibitor of Apoptosis Protein-2 and Suppresses Apoptosis of Colon Cancer Cells through ERK1/2 and p38 MAPK* , 2004, Journal of Biological Chemistry.
[17] P. Pahwa,et al. Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia. , 2004, Journal of the National Cancer Institute.
[18] Marc Nasoff,et al. Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. , 2004, Cancer cell.
[19] Chunying Du,et al. Smac/DIABLO Selectively Reduces the Levels of c-IAP1 and c-IAP2 but Not That of XIAP and Livin in HeLa Cells* , 2004, Journal of Biological Chemistry.
[20] Ying Qi,et al. Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization* , 2003, Journal of Biological Chemistry.
[21] E. White,et al. DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells. , 2003, Genes & development.
[22] Jinyu Ren,et al. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. , 2003, Genes & development.
[23] P. Hersey,et al. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria , 2003, Oncogene.
[24] Wafik S El-Deiry,et al. Bioluminescent Molecular Imaging of Endogenous and Exogenous p53-Mediated Transcription In Vitro and In Vivo Using an HCT116 Human Colon Carcinoma Xenograft Model , 2003, Cancer biology & therapy.
[25] S. Srinivasula,et al. Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.
[26] J Downward,et al. Caspase-6 is the direct activator of caspase-8 in the cytochrome c-induced apoptosis pathway: absolute requirement for removal of caspase-6 prodomain , 2002, Cell Death and Differentiation.
[27] J. Sedivy,et al. c-Myc Sensitizes Cells to Tumor Necrosis Factor-mediated Apoptosis by Inhibiting Nuclear Factor κB Transactivation* , 2002, The Journal of Biological Chemistry.
[28] S. Korsmeyer,et al. c-Myc Functionally Cooperates with Bax To Induce Apoptosis , 2002, Molecular and Cellular Biology.
[29] C. Albanese,et al. E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. , 2002, Molecular cell.
[30] R. Ravi,et al. Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). , 2002, Cancer research.
[31] Peter Schow,et al. Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax , 2002, Nature Medicine.
[32] Luca Scorrano,et al. A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. , 2002, Developmental cell.
[33] Wafik S El-Deiry,et al. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. , 2002, Neoplasia.
[34] T. Burns,et al. Identification of inhibitors of TRAIL-induced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. , 2001, The Journal of biological chemistry.
[35] G. Cohen,et al. Modulation of Tumor Necrosis Factor Apoptosis-inducing Ligand- induced NF-κB Activation by Inhibition of Apical Caspases* , 2001, The Journal of Biological Chemistry.
[36] D. Andrews,et al. Myc Potentiates Apoptosis by Stimulating Bax Activity at the Mitochondria , 2001, Molecular and Cellular Biology.
[37] S. E. F. Tran,et al. MAPK/ERK Overrides the Apoptotic Signaling from Fas, TNF, and TRAIL Receptors* , 2001, The Journal of Biological Chemistry.
[38] S. Korsmeyer,et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.
[39] John Calvin Reed,et al. Bax is a transcriptional target and mediator of c-myc-induced apoptosis. , 2000, Cancer research.
[40] K. Kinzler,et al. Role of BAX in the apoptotic response to anticancer agents. , 2000, Science.
[41] H. Shu,et al. Tumor Necrosis Factor-related Apoptosis-inducing Ligand Receptors Signal NF-κB and JNK Activation and Apoptosis through Distinct Pathways* , 1999, The Journal of Biological Chemistry.
[42] Min-Liang Kuo,et al. The Antiapoptotic Gene mcl-1 Is Up-Regulated by the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway through a Transcription Factor Complex Containing CREB , 1999, Molecular and Cellular Biology.
[43] G. Evan,et al. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. , 1999, Genes & development.
[44] C. Y. Wang,et al. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. , 1998, Science.
[45] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[46] A. Strasser,et al. Bim: a novel member of the Bcl‐2 family that promotes apoptosis , 1998, The EMBO journal.
[47] G. Evan,et al. Induction of TNF‐sensitive cellular phenotype by c‐Myc involves p53 and impaired NF‐κB activation , 1997, The EMBO journal.
[48] John Calvin Reed,et al. The c‐IAP‐1 and c‐IAP‐2 proteins are direct inhibitors of specific caspases , 1997, The EMBO journal.
[49] Margot Thome,et al. Inhibition of death receptor signals by cellular FLIP , 1997, Nature.
[50] D. Goeddel,et al. Casper is a FADD- and caspase-related inducer of apoptosis. , 1997, Immunity.
[51] Shigeo Ohno,et al. Protein Kinase C δ Activates the MEK-ERK Pathway in a Manner Independent of Ras and Dependent on Raf* , 1996, The Journal of Biological Chemistry.
[52] C. Ito,et al. Three NF-χB sites in the IχB-α promoter are required for induction of gene expression by TNFα , 1994 .
[53] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[54] J. Cleveland,et al. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. , 1991, Oncogene.